TrialMatch

Sign in Sign up Create account

Search the registry

Find clinical trials

Searching 2,585 mirrored studies from ClinicalTrials.gov. Create a profile to see personalised match scores.

Filters

Clear all

2,585 studies found

Sort by

Recruiting

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Phase 1 · 9 sites

Compare

Recruiting

A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies

Phase 1 · 19 sites

Compare

Recruiting

A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D

Phase 1 / Phase 2 · 1 site

Compare

Recruiting

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

Phase 3 · 7 sites

Compare

Recruiting

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

Phase 2 · 9 sites

Compare

Recruiting

Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing

1 site

Compare

Recruiting

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Phase 2 · 10 sites

Compare

Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Phase 3 · 372 sites

Compare

Recruiting

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

Phase 2 · 30 sites

Compare

Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Phase 1 · 7 sites

Compare

Recruiting

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Phase 1 · 13 sites

Compare

Recruiting

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Phase 2 · 2 sites

Compare

Potential match only. Final eligibility is determined by the study team.